New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

12

New U.S. Covid-19 cases hit plateau after steep drops

The United States reported a 3 percent decline in new cases of Covid-19 for the week ended Feb. 28, a much smaller drop than in the previous six weeks, and health officials warned that progress against the global pandemic was stalling.

14

Merck Voluntarily Withdrawing Keytruda for Metastatic SCLC

Merck announced on March 1 the voluntary withdrawal of the U.S. indication for Keytruda (pembrolizumab) for the treatment of patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy and at least one other prior line of therapy.

20

FDA Approves Oncopeptides’ Pepaxto for Triple-Class Refractory Multiple Myeloma

The U.S. Food and Drug Administration approved Oncopeptides AB’s Pepaxto (melphalan flufenamide) in combination with dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one CD38-directed monoclonal antibody.